{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:05:16Z","timestamp":1781625916084,"version":"3.54.5"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["DNA Repair"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.dnarep.2026.103940","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:05:02Z","timestamp":1778889902000},"page":"103940","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["From DNA repair to neurodegeneration: PARP1 mechanisms and inhibitor strategies in Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"163","author":[{"given":"Purusottam","family":"Banjare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4500-9167","authenticated-orcid":false,"given":"Richa","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dnarep.2026.103940_bib1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1101\/gad.291518.116","article-title":"PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes","volume":"31","author":"Gupte","year":"2017","journal-title":"Genes Dev."},{"key":"10.1016\/j.dnarep.2026.103940_bib2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4103\/1673-5374.150653","article-title":"Multiple facets of poly(ADP-ribose) polymerase-1 in neurological diseases","volume":"10","author":"Sriram","year":"2015","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.dnarep.2026.103940_bib3","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1206840","article-title":"DNA damage, neurodegeneration, and synaptic plasticity","volume":"2016","author":"Merlo","year":"2016","journal-title":"Neural Plast."},{"key":"10.1016\/j.dnarep.2026.103940_bib4","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/bies.20085","article-title":"The PARP superfamily","volume":"26","author":"Am\u00e9","year":"2004","journal-title":"Bioessays"},{"key":"10.1016\/j.dnarep.2026.103940_bib5","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0968-0004(00)89089-1","article-title":"Post-translational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks","volume":"20","author":"Lindahl","year":"1995","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.dnarep.2026.103940_bib6","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1200\/JCO.2014.56.2728","article-title":"Olaparib monotherapy in patients with advanced cancer and a germline BRCA1\/2 mutation","volume":"33","author":"Kaufman","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.dnarep.2026.103940_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8040435","article-title":"PARP inhibitors as a therapeutic agent for homologous recombination deficiency in breast cancers","volume":"8","author":"Keung","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.dnarep.2026.103940_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-022-30785-8","article-title":"Cis- and trans-resveratrol have opposite effects on histone serine-ADP-ribosylation and tyrosine induced neurodegeneration","volume":"13","author":"Jhanji","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.dnarep.2026.103940_bib9","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1111\/febs.15716","article-title":"The role of PARP1 in neurodegenerative diseases and aging","volume":"289","author":"Mao","year":"2022","journal-title":"FEBS J."},{"key":"10.1016\/j.dnarep.2026.103940_bib10","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.semcdb.2016.11.007","article-title":"Poly(ADP-ribose)polymerase-1 hyperactivation in neurodegenerative diseases: The death knell tolls for neurons","volume":"63","author":"Narne","year":"2017","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.dnarep.2026.103940_bib11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.mad.2015.04.001","article-title":"PARP-1 involvement in neurodegeneration: a focus on Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"146\u2013148","author":"Martire","year":"2015","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.dnarep.2026.103940_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-8-152","article-title":"Poly(ADP-ribose)polymerase-1 modulates microglial responses to amyloid \u03b2","volume":"8","author":"Kauppinen","year":"2011","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.dnarep.2026.103940_bib13","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.1021\/acsomega.0c06168","article-title":"Computational analysis indicates that PARP1 acts as a histone deacetylases interactor sharing common lysine residues for acetylation, ubiquitination, and SUMOylation in Alzheimer\u2019s and Parkinson\u2019s Disease","volume":"6","author":"Gupta","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.dnarep.2026.103940_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.873929","article-title":"Dihuang-Yinzi alleviates cognition deficits via targeting energy-related metabolism in an alzheimer mouse model as demonstrated by integration of metabolomics and network pharmacology","volume":"14","author":"Han","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.dnarep.2026.103940_bib15","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.cmet.2019.09.001","article-title":"NAD+ in brain aging and neurodegenerative disorders","volume":"30","author":"Lautrup","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.dnarep.2026.103940_bib16","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/jcla.20379","article-title":"Evaluation of the poly(ADP-ribose) polymerase-1 gene variants in Alzheimer\u2019s disease","volume":"24","author":"Liu","year":"2010","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.dnarep.2026.103940_bib17","article-title":"Chronic treatment with baicalein alleviates behavioural disorders and improves cerebral blood flow via reverting metabolic abnormalities in a J20 transgenic mouse model of Alzheimer\u2019s disease","volume":"28","author":"Zhang","year":"2023","journal-title":"Brain Behav. Immun. Health"},{"key":"10.1016\/j.dnarep.2026.103940_bib18","article-title":"Alzheimer\u2019s disease drug development pipeline: 2024","volume":"10","author":"Cummings","year":"2024","journal-title":"Alzheimers Dement. (N. Y)"},{"key":"10.1016\/j.dnarep.2026.103940_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2020.00255","article-title":"Nicotinamide, a poly [ADP-Ribose] polymerase 1 (PARP-1) inhibitor, as an adjunctive therapy for the treatment of Alzheimer\u2019s disease","volume":"12","author":"Salech","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.dnarep.2026.103940_bib20","doi-asserted-by":"crossref","unstructured":"Phelan, M.J., Ruth A.Mulnard, Gillen, D.L., and Schreiber, S.S. (2017). Phase II Clinical Trial of Nicotinamide for the Treatment of Mild to Moderate Alzheimer\u2019s Disease | ClinMed International Library | Journal of Geriatric Medicine and Gerontology.","DOI":"10.23937\/2469-5858\/1510021"},{"key":"10.1016\/j.dnarep.2026.103940_bib21","doi-asserted-by":"crossref","first-page":"4770","DOI":"10.1016\/S0021-9258(17)42913-9","article-title":"Poly(ADP-ribose) synthetase. Separation and identification of three proteolytic fragments as the substrate-binding domain, the DNA-binding domain, and the automodification domain","volume":"259","author":"Kameshita","year":"1984","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.dnarep.2026.103940_bib22","doi-asserted-by":"crossref","first-page":"30069","DOI":"10.1074\/jbc.273.46.30069","article-title":"Poly(ADP-ribose) polymerase null mouse cells synthesize ADP-ribose polymers","volume":"273","author":"Shieh","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.dnarep.2026.103940_bib23","doi-asserted-by":"crossref","first-page":"18877","DOI":"10.1074\/jbc.M110.105668","article-title":"The Zn3 domain of human poly(ADP-ribose) polymerase-1 (PARP-1) functions in both DNA-dependent poly(ADP-ribose) synthesis activity and chromatin compaction","volume":"285","author":"Langelier","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.dnarep.2026.103940_bib24","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1074\/jbc.M708558200","article-title":"A third zinc-binding domain of human poly(ADP-ribose) polymerase-1 coordinates DNA-dependent enzyme activation","volume":"283","author":"Langelier","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.dnarep.2026.103940_bib25","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1021\/bi800018a","article-title":"Domain C of human poly(ADP-ribose) polymerase-1 is important for enzyme activity and contains a novel zinc-ribbon motif","volume":"47","author":"Tao","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.dnarep.2026.103940_bib26","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0167-4838(91)99007-F","article-title":"Enzymological properties of poly(ADP-ribose)polymerase: characterization of automodification sites and NADase activity","volume":"1078","author":"Desmarais","year":"1991","journal-title":"Biochim. Et. Biophys. Acta - Protein Struct. Mol. Enzymol."},{"key":"10.1016\/j.dnarep.2026.103940_bib27","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1093\/nar\/24.22.4387","article-title":"XRCC1 polypeptide interacts with DNA polymerase beta and possibly poly (ADP-ribose) polymerase, and DNA ligase III is a novel molecular \u2018nick-sensor\u2019 in vitro","volume":"24","author":"Caldecott","year":"1996","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.dnarep.2026.103940_bib28","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1128\/MCB.18.6.3563","article-title":"XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage","volume":"18","author":"Masson","year":"1998","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.dnarep.2026.103940_bib29","doi-asserted-by":"crossref","first-page":"23028","DOI":"10.1074\/jbc.M202390200","article-title":"Poly(ADP-ribose) polymerase-2 (PARP-2) is required for efficient base excision DNA repair in association with PARP-1 and XRCC1","volume":"277","author":"Schreiber","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.dnarep.2026.103940_bib30","doi-asserted-by":"crossref","first-page":"14670","DOI":"10.1021\/bi050755o","article-title":"DNA-induced dimerization of poly(ADP-ribose) polymerase-1 triggers its activation","volume":"44","author":"Pion","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.dnarep.2026.103940_bib31","doi-asserted-by":"crossref","first-page":"14258","DOI":"10.1021\/ja906135d","article-title":"Identification of the ADP-ribosylation sites in the PARP-1 automodification domain: analysis and implications","volume":"131","author":"Tao","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.dnarep.2026.103940_bib32","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1016\/j.molcel.2022.02.021","article-title":"The expanding universe of PARP1-mediated molecular and therapeutic mechanisms","volume":"82","author":"Huang","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.dnarep.2026.103940_bib33","author":"Malanga","year":"2013","journal-title":"DNA Damage Signaling through Poly(ADP-Ribose)"},{"issue":"4","key":"10.1016\/j.dnarep.2026.103940_bib34","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1093\/nar\/gki266","article-title":"Human base excision repair enzymes apurinic\/apyrimidinic endonuclease1 (APE1), DNA polymerase beta and poly(ADP-ribose) polymerase 1: interplay between strand-displacement DNA synthesis and proofreading exonuclease activity","volume":"33","author":"Sukhanova","year":"2005","journal-title":"Nucleic. Acids. Res."},{"issue":"4","key":"10.1016\/j.dnarep.2026.103940_bib35","first-page":"279","article-title":"Complex Roles of NEIL1 and OGG1: Insights Gained from Murine Knockouts and Human Polymorphic Variants","volume":"2","author":"Lloyd","year":"2022","journal-title":"DNA (Basel)."},{"issue":"10","key":"10.1016\/j.dnarep.2026.103940_bib36","doi-asserted-by":"crossref","first-page":"6337","DOI":"10.1093\/nar\/gku288","article-title":"Suicidal cross-linking of PARP-1 to AP site intermediates in cells undergoing base excision repair","volume":"42","author":"Prasad","year":"2014","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.dnarep.2026.103940_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/biom15060890","article-title":"Protein-Protein Interactions in Base Excision Repair","volume":"15","author":"Rathnaiah","year":"2025","journal-title":"Biomolecules"},{"issue":"8","key":"10.1016\/j.dnarep.2026.103940_bib38","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1093\/nar\/gkv250","article-title":"Disruption of PARP1 function inhibits base excision repair of a sub-set of DNA lesions","volume":"43","author":"Reynolds","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"10","key":"10.1016\/j.dnarep.2026.103940_bib39","doi-asserted-by":"crossref","first-page":"674","DOI":"10.18632\/aging.100492","article-title":"Coordination of DNA repair by NEIL1 and PARP-1: a possible link to aging","volume":"4","author":"Noren Hooten","year":"2012","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"10.1016\/j.dnarep.2026.103940_bib40","doi-asserted-by":"crossref","first-page":"zcab003","DOI":"10.1093\/narcan\/zcab003","article-title":"Top1-PARP1 association and beyond: from DNA topology to break repair","volume":"3","author":"Chowdhuri","year":"2021","journal-title":"NAR Cancer"},{"issue":"1","key":"10.1016\/j.dnarep.2026.103940_bib41","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s10565-022-09739-9","article-title":"PARP1 and XRCC1 exhibit a reciprocal relationship in genotoxic stress response","volume":"39","author":"Reber","year":"2023","journal-title":"Cell Biol. Toxicol."},{"issue":"5","key":"10.1016\/j.dnarep.2026.103940_bib42","first-page":"2546","article-title":"Overlapping roles for PARP1 and PARP2 in the recruitment of endogenous XRCC1 and PNKP into oxidized chromatin","volume":"45","author":"Hanzlikova","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.dnarep.2026.103940_bib43","doi-asserted-by":"crossref","first-page":"gkaf086","DOI":"10.1093\/nar\/gkaf086","article-title":"XRCC1 mediates PARP1- and PAR-dependent recruitment of PARP2 to DNA damage sites","volume":"53","author":"Lin","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.dnarep.2026.103940_bib44","doi-asserted-by":"crossref","first-page":"7481","DOI":"10.1073\/pnas.93.15.7481","article-title":"Structure of the catalytic fragment of poly(AD-ribose) polymerase from chicken","volume":"93","author":"Ruf","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.dnarep.2026.103940_bib45","doi-asserted-by":"crossref","first-page":"13454","DOI":"10.1016\/S0021-9258(19)38671-5","article-title":"The carboxyl-terminal domain of human poly(ADP-ribose) polymerase: overproduction in Escherichia coli, large scale purification, and characterization","volume":"268","author":"Simonin","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.dnarep.2026.103940_bib46","doi-asserted-by":"crossref","first-page":"17076","DOI":"10.1074\/jbc.M413483200","article-title":"Regulation of poly(ADP-ribose) polymerase-1 by DNA structure-specific binding","volume":"280","author":"Lonskaya","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.dnarep.2026.103940_bib47","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jmb.2005.03.010","article-title":"Specific binding of poly(ADP-ribose) polymerase-1 to cruciform hairpins","volume":"348","author":"Potaman","year":"2005","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.dnarep.2026.103940_bib48","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.cell.2004.11.002","article-title":"NAD+-dependent modulation of chromatin structure and transcription by nucleosome binding properties of PARP-1","volume":"119","author":"Kim","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.dnarep.2026.103940_bib49","doi-asserted-by":"crossref","first-page":"7475","DOI":"10.1128\/MCB.01314-07","article-title":"The DNA binding and catalytic domains of poly(ADP-ribose) polymerase 1 cooperate in the regulation of chromatin structure and transcription","volume":"27","author":"Wacker","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.dnarep.2026.103940_bib50","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.cbpa.2007.08.038","article-title":"Poly(ADP-ribose) makes a date with death","volume":"11","author":"Heeres","year":"2007","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.dnarep.2026.103940_bib51","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1101\/gad.1331805","article-title":"Poly(ADP-ribosyl)ation by PARP-1: \u2018PAR-laying\u2019 NAD+ into a nuclear signal","volume":"19","author":"Kim","year":"2005","journal-title":"Genes Dev."},{"key":"10.1016\/j.dnarep.2026.103940_bib52","doi-asserted-by":"crossref","first-page":"18308","DOI":"10.1073\/pnas.0606526103","article-title":"Poly(ADP-ribose) (PAR) polymer is a death signal","volume":"103","author":"Andrabi","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.dnarep.2026.103940_bib53","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s00018-008-7516-5","article-title":"The roles of poly(ADP-ribose)-metabolizing enzymes in alkylation-induced cell death","volume":"65","author":"Cohausz","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.dnarep.2026.103940_bib54","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.neuroscience.2007.04.062","article-title":"Spatial and functional relationship between poly(ADP-ribose) polymerase-1 and poly(ADP-ribose) glycohydrolase in the brain","volume":"148","author":"Poitras","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.dnarep.2026.103940_bib55","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.pneurobio.2012.03.005","article-title":"Defining Alzheimer as a common age-related neurodegenerative process not inevitably leading to dementia","volume":"97","author":"Ferrer","year":"2012","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.dnarep.2026.103940_bib56","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ene.13439","article-title":"Alzheimer\u2019s disease","volume":"25","author":"Lane","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.dnarep.2026.103940_bib57","doi-asserted-by":"crossref","first-page":"9553","DOI":"10.1523\/JNEUROSCI.1512-09.2009","article-title":"Poly-(ADP-Ribose) polymerase-1 is necessary for long-term facilitation in Aplysia","volume":"29","author":"Hern\u00e1ndez","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.dnarep.2026.103940_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13041-015-0153-7","article-title":"PARP-1 activity is required for the reconsolidation and extinction of contextual fear memory","volume":"8","author":"Inaba","year":"2015","journal-title":"Mol. Brain"},{"key":"10.1016\/j.dnarep.2026.103940_bib59","first-page":"6","article-title":"A PARP1-ERK2 synergism is required for the induction of LTP","author":"Visochek","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.dnarep.2026.103940_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104364","article-title":"Nucleolar integrity is required for the maintenance of long-term synaptic plasticity","volume":"9","author":"Allen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.dnarep.2026.103940_bib61","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4383258","article-title":"Evidence for decreased nucleolar PARP-1 as an early marker of cognitive impairment","volume":"2019","author":"Regier","year":"2019","journal-title":"Neural Plast."},{"issue":"21","key":"10.1016\/j.dnarep.2026.103940_bib62","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1158\/0008-5472.CAN-12-2753","article-title":"Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors","volume":"72","author":"Murai","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.dnarep.2026.103940_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105397","article-title":"ADP-ribose contributions to genome stability and PARP enzyme trapping on sites of DNA damage; paradigm shifts for a coming-of-age modification","volume":"299","author":"Rouleau-Turcotte","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.dnarep.2026.103940_bib64","doi-asserted-by":"crossref","first-page":"40364","DOI":"10.1074\/jbc.M509329200","article-title":"SIRT1 protects against microglia-dependent amyloid-\u03b2 toxicity through inhibiting NF-\u03baB signaling","volume":"280","author":"Chen","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.dnarep.2026.103940_bib65","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.4049\/jimmunol.174.4.2288","article-title":"Poly(ADP-ribose) polymerase-1 promotes microglial activation, proliferation, and matrix metalloproteinase-9-mediated neuron death","volume":"174","author":"Kauppinen","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.dnarep.2026.103940_bib66","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/brb3.239","article-title":"PARP1 enhances inflammatory cytokine expression by alteration of promoter chromatin structure in microglia","volume":"4","author":"Mart\u00ednez-Zamudio","year":"2014","journal-title":"Brain Behav."},{"issue":"2","key":"10.1016\/j.dnarep.2026.103940_bib67","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.nrl.2012.12.007","article-title":"Astrocytes in neurodegenerative diseases (I): function and molecular description","volume":"30","author":"Guillam\u00f3n-Vivancos","year":"2015","journal-title":"Neurologia"},{"key":"10.1016\/j.dnarep.2026.103940_bib68","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1471-4159.2008.05403.x","article-title":"Poly (ADP-ribose) polymerases (PARPs) 1-3 regulate astrocyte activation","volume":"106","author":"Phulwani","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.dnarep.2026.103940_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/cells9010041","article-title":"Multifaceted role of PARP-1 in DNA repair and inflammation: pathological and therapeutic implications in cancer and non-cancer diseases","volume":"9","author":"Pazzaglia","year":"2019","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.dnarep.2026.103940_bib70","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/sj.bjp.0704934","article-title":"Inhibitors of poly(ADP-ribose) polymerase-1 suppress transcriptional activation in lymphocytes and ameliorate autoimmune encephalomyelitis in rats","volume":"137","author":"Chiarugi","year":"2002","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.dnarep.2026.103940_bib71","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/nar\/gkh239","article-title":"Transcription regulation of TNF-alpha-early response genes by poly(ADP-ribose) polymerase-1 in murine heart endothelial cells","volume":"32","author":"Carrillo","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.dnarep.2026.103940_bib72","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1148\/radiol.2016152244","article-title":"Blood-brain barrier leakage in patients with early Alzheimer Disease","volume":"281","author":"Haar","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.dnarep.2026.103940_bib73","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neurobiolaging.2018.06.004","article-title":"The effects of cerebral amyloid angiopathy on integrity of the blood-brain barrier","volume":"70","author":"Magaki","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.dnarep.2026.103940_bib74","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/jcbfm.2014.167","article-title":"Poly(ADP-ribose) polymerase-1 inhibition in brain endothelium protects the blood\u2014brain barrier under physiologic and neuroinflammatory conditions","volume":"35","author":"Rom","year":"2015","journal-title":"J. Cereb. Blood Flow. Metab."},{"issue":"4","key":"10.1016\/j.dnarep.2026.103940_bib75","doi-asserted-by":"crossref","first-page":"288","DOI":"10.14283\/jpad.2020.28","article-title":"The Role of Clinical Trials in Preclinical Alzheimer's Disease Drug Development Programs","volume":"7","author":"Cummings","year":"2020","journal-title":"J. Prev. Alzheimers Dis."},{"issue":"5","key":"10.1016\/j.dnarep.2026.103940_bib76","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/s43587-023-00410-4","article-title":"Detection and treatment of Alzheimer's disease in its preclinical stage","volume":"3","author":"Rafii","year":"2023","journal-title":"Nat. Aging."},{"key":"10.1016\/j.dnarep.2026.103940_bib77","article-title":"Poly(ADP-ribose) Polymerase 1 Deficiency Attenuates Amyloid Pathology","author":"Jhaldiyal","year":"2025","journal-title":"Neurodegener. Cogn. Decline Fam. Alzheimer's Dis. Model"},{"issue":"8","key":"10.1016\/j.dnarep.2026.103940_bib78","doi-asserted-by":"crossref","first-page":"E1876","DOI":"10.1073\/pnas.1718819115","article-title":"NAD+ supplementation normalizes key Alzheimer's features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency","volume":"115","author":"Hou","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.dnarep.2026.103940_bib79","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neurobiolaging.2020.05.013","article-title":"5XFAD mice show early-onset gap encoding deficits in the auditory cortex","volume":"94","author":"Weible","year":"2020","journal-title":"Neurobiol. Aging."},{"issue":"12","key":"10.1016\/j.dnarep.2026.103940_bib80","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.3390\/biom14121556","article-title":"Pathobiochemistry of Aging and Neurodegeneration: Deregulation of NAD+ Metabolism in Brain Cells","volume":"14","author":"Kolotyeva","year":"2024","journal-title":"Biomolecules"},{"issue":"7","key":"10.1016\/j.dnarep.2026.103940_bib81","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/gerona\/glr039","article-title":"Age-dependent increases in apoptosis\/necrosis ratios in human lymphocytes exposed to oxidative stress","volume":"66","author":"Behrens","year":"2011","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"2","key":"10.1016\/j.dnarep.2026.103940_bib82","article-title":"for Alzheimer's Disease Neuroimaging Initiative. Therapeutic time window of disease-modifying therapy for early Alzheimer's disease","volume":"11","author":"Nakashima","year":"2025","journal-title":"Alzheimers Dement. (N Y)."},{"key":"10.1016\/j.dnarep.2026.103940_bib83","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2013.00301","article-title":"Structural implications for selective targeting of PARPs","volume":"3","author":"Steffen","year":"2013","journal-title":"Front. Oncol."},{"key":"10.1016\/j.dnarep.2026.103940_bib84","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/bph.13748","article-title":"Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases","volume":"175","author":"Berger","year":"2018","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.dnarep.2026.103940_bib85","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.dnarep.2018.08.022","article-title":"The comings and goings of PARP-1 in response to DNA damage","volume":"71","author":"Pascal","year":"2018","journal-title":"DNA Repair (Amst. )"},{"key":"10.1016\/j.dnarep.2026.103940_bib86","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18102111","article-title":"PARP1 in Carcinomas and PARP1 inhibitors as antineoplastic drugs","volume":"18","author":"Wang","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.dnarep.2026.103940_bib87","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-05031-9","article-title":"Analysis of PARP inhibitor toxicity by multidimensional fluorescence microscopy reveals mechanisms of sensitivity and resistance","volume":"9","author":"Michelena","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.dnarep.2026.103940_bib88","doi-asserted-by":"crossref","first-page":"11500","DOI":"10.1523\/JNEUROSCI.3203-08.2008","article-title":"Nicotinamide restores cognition in Alzheimer\u2019s disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau","volume":"28","author":"Green","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.dnarep.2026.103940_bib89","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2011226118","article-title":"NAD+ supplementation reduces neuroinflammation and cell senescence in a transgenic mouse model of Alzheimer\u2019s disease via cGAS\u2013STING","volume":"118","author":"Hou","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.dnarep.2026.103940_bib90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-024-07062-1","article-title":"NAD+-boosting agent nicotinamide mononucleotide potently improves mitochondria stress response in Alzheimer\u2019s disease via ATF4-dependent mitochondrial UPR","volume":"15","author":"Xiong","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.dnarep.2026.103940_bib91","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s11011-018-0346-8","article-title":"Nicotinamide ribose ameliorates cognitive impairment of aged and Alzheimer\u2019s disease model mice","volume":"34","author":"Xie","year":"2019","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.dnarep.2026.103940_bib92","article-title":"Pharmacokinetic and pharmacodynamic assessment of oral nicotinamide in the NEAT clinical trial for early Alzheimer\u2019s disease","volume":"17","author":"Ketron","year":"2025","journal-title":"Alzheimer\u2019s Res. Ther."},{"issue":"13","key":"10.1016\/j.dnarep.2026.103940_bib93","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1038\/sj.emboj.7601758","article-title":"SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis","volume":"26","author":"Kim","year":"2007","journal-title":"EMBO J."},{"issue":"6","key":"10.1016\/j.dnarep.2026.103940_bib94","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.neurobiolaging.2012.12.005","article-title":"Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-\u03b3 coactivator 1\u03b1 regulated \u03b2-secretase 1 degradation and mitochondrial gene expression in Alzheimer's mouse models","volume":"34","author":"Gong","year":"2013","journal-title":"Neurobiol. Aging."},{"key":"10.1016\/j.dnarep.2026.103940_bib95","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000210152","article-title":"Phase 2A proof-of-concept double-blind, randomized, placebo-controlled trial of nicotinamide in early Alzheimer disease","volume":"104","author":"Grill","year":"2025","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.dnarep.2026.103940_bib96","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1158\/1541-7786.MCR-15-0191-T","article-title":"Mechanistic Dissection of PARP1 Trapping and the Impact on In Vivo Tolerability and Efficacy of PARP Inhibitors","volume":"13","author":"Hopkins","year":"2015","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.dnarep.2026.103940_bib97","first-page":"15220","article-title":"Poly(ADP-ribose) polymerase 1 is a novel target to promote axonal regeneration","volume":"112","author":"rochier","year":"2015"},{"issue":"8","key":"10.1016\/j.dnarep.2026.103940_bib98","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134482","article-title":"PARP-1 Inhibition Is Neuroprotective in the R6\/2 Mouse Model of Huntington's Disease","volume":"10","author":"Cardinale","year":"2015","journal-title":"PLoS One"},{"issue":"7635","key":"10.1016\/j.dnarep.2026.103940_bib99","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nature20790","article-title":"Care4Rare Canada Consortium; Yoon G, Caldecott KW. XRCC1 mutation is associated with PARP1 hyperactivation and cerebellar ataxia","volume":"541","author":"Hoch","year":"2017","journal-title":"Nature"}],"container-title":["DNA Repair"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568786426000194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568786426000194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:10:11Z","timestamp":1781622611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568786426000194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":99,"alternative-id":["S1568786426000194"],"URL":"https:\/\/doi.org\/10.1016\/j.dnarep.2026.103940","relation":{},"ISSN":["1568-7864"],"issn-type":[{"value":"1568-7864","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From DNA repair to neurodegeneration: PARP1 mechanisms and inhibitor strategies in Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"DNA Repair","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dnarep.2026.103940","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103940"}}